feed,title,long_url,short_url
Benzinga,"Infectious Disease Player Vir Biotech Has Limited Near Term Upside, Analyst Downgrades",https://benzinga.com/analyst-ratings/analyst-color/23/09/34363871/infectious-disease-player-vir-biotech-has-limited-near-term-upside-analyst-downgrad,https://da.gd/06T2
Benzinga,Guidewire's Cloud Transition Pays Off Early: Analyst Raises Price Target Amid Margin Gains,https://benzinga.com/analyst-ratings/analyst-color/23/09/34365649/guidewires-cloud-transition-pays-off-early-analyst-raises-price-target-amid-margin-,https://da.gd/4ZNrG
Benzinga,Alibaba's Freshippo IPO Plans Take a Backseat as Valuation Expectations Adjust,https://benzinga.com/news/23/09/34366498/alibabas-freshippo-ipo-plans-take-a-backseat-as-valuation-expectations-adjust,https://da.gd/7KfTq7
